US Stocks
/
Virax Biolabs Group Limited Share Price

Virax Biolabs Group Limited Share Price

NASDAQ: VRAX
$1.94
-$0.13 (-6.28%) Last updated on 09 Oct, 2026 | 01:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Virax Biolabs Group Limited Stock Performance

Open
$2.06
Prev. Close
$2.07
Circuit Range
N/A
Day Range
$1.94 - $2.06
Year Range
$0.10 - $13.18
Volume
392
Average Traded
$2.01

Virax Biolabs Group Limited Share Price Today

As of 9 October 2026, Virax Biolabs Group Limited's share price is $1.94. The stock opened at $2.06, compared to its previous close of $2.07. During today's trading session, Virax Biolabs Group Limited's share price traded between $1.94 and $2.06, with an average price of $2.00. Over the past 52 weeks, the stock has recorded a high of $13.18 and a low of $0.10. In terms of performance, Virax Biolabs Group Limited's share price has risen by 1403.88% over the last six months and is up 245.20% on a year-on-year basis.

Virax Biolabs Group Limited Share Price Chart

$1.94$2.06
L
Show Current Price
H

Virax Biolabs Group Limited Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$10.00M
Return On Equity (TTM)
N/A
Profit Margin
-50200.00%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Virax Biolabs Group Limited Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.01$0.16$0.01$0.01
Net Profit-$5.46-$6.73-$6.06-$5.02
Net Profit Margin-54600.00%-4206.25%-60600.00%-50200.00%
Income ChangeN/A-23.26%9.96%17.16%

About Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Virax Biolabs Group Limited Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.23
$1.94
-11.82%
Sep 2026
$2.76
$2.20
-24.66%
Aug 2026
$2.78
$2.92
-2.01%
Jul 2026
$2.64
$2.98
+1.19%
Jun 2026
$0.19
$2.94
+1,509.29%
May 2026
$0.13
$0.18
+41.86%
Apr 2026
$0.18
$0.13
-40.28%
Mar 2026
$0.22
$0.22
-1.37%
Feb 2026
$0.28
$0.22
-20.07%
Jan 2026
$0.39
$0.27
-29.02%
Dec 2025
$0.40
$0.39
-2.28%
Nov 2025
$0.55
$0.40
-29.72%

VRAX Share Price FAQs

What is Virax Biolabs Group Limited share price today?

chevron-up
Virax Biolabs Group Limited share price today is $1.94 as on October 9, 2026 at 1:22 am IST.

What is the 52 week high and 52 week low of Virax Biolabs Group Limited stock?

chevron-up
The 52 week high of Virax Biolabs Group Limited stock is $13.18, while the 52 week low is $0.10 as of 9 Oct '26.

What is the 5 year returns of VRAX?

chevron-up
The 5 year returns of VRAX is -96.41% as on 9 Oct '26.

What is the high & low stock price of VRAX today?

chevron-up
VRAX stock price hit a high of $2.06 and low of $1.94 as of 9 Oct '26.

Can I buy VRAX shares in India?

chevron-up
Yes. You can buy VRAX in India by opening an international trading account.